Clinical & economic evidence
Measured at national scale. Published in the peer-reviewed literature. Submitted to CMS.
Our outcomes are drawn from the full monitored population rather than selected cohorts, stratified against the obvious confounders, and reported as associations where the design is observational.
Two ways in
Outcomes
The data. Peer-reviewed publications, national platform analyses, cost and utilization results, and the methods behind them.
View the outcomes →Customer Stories
The people. What partnering with HealthSnap looks like, from health-system executives to the patients managing conditions at home.
Read the stories →
Start here
The full evidence base, as submitted to CMS.
1,354,099Where this number comes fromPopulation14,503 patientsSourceCMS evidence binder, Aug 2026VerifiedAugust 2026Observational and single-arm — reported as an association, not causation.
care-navigation notes, 14,503 patients
18.5 vs 14.9 mmHg
systolic reduction, navigated vs not, 68,431-patient within-platform comparison
−$10,932Where this number comes fromPopulation597 high-acuity Medicare beneficiariesSourceTelemedicine and e-Health, 2026 · DOI pendingVerifiedAugust 2026Observational and single-arm — reported as an association, not causation.
median annual total cost of care per patient, 597 high-acuity Medicare beneficiaries
- Two peer-reviewed publications
- Platform analysis, 30,098 patients
- Five AHA Scientific Sessions presentations
- Care-navigation white paper
Compiled for the Centers for Medicare & Medicaid Services in August 2026 by our Chief Scientific Officer, with limitations and conflicts disclosed throughout.
See what continuous care does for your population.
We will bring the Chief Scientific Officer.